After reporting robust results, Resmed reckons it won't be subject to US tariffs while the growth of anti-obesity drugs will be a tailwind.

ResMed launched NightOwl™, a home sleep apnea test that enhances user convenience with a small fingertip sensor and cloud data evaluation. Despite the broader market reacting negatively to new ...

SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD ... to 10 nights of sleep data for a single patient, capturing night-to-night variability and providing clinicians with a ...

It also simplifies the process for providers. This is a meaningful step forward in Resmed’s mission to deliver life-changing health technology that people love.” NightOwl is a disposable HSAT device ...

It also simplifies the process for providers. This is a meaningful step forward in Resmed's mission to deliver life-changing health technology that people love.” NightOwl is a disposable HSAT device ...

Nunez, M.D., Chief Medical Officer at Resmed.“With NightOwl ... up to 10 nights of sleep data for a single patient, capturing night-to-night variability and providing clinicians with a ...

(RTTNews) - ResMed Inc.(RMD), announced Thursday that ... up to 10 nights of sleep data for a single patient, capturing night-to-night variability and providing clinicians with a comprehensive ...

Resmed Inc. RMD recently launched its home sleep ... up to 10 nights of sleep data for a single patient, including night-to-night variability and a comprehensive view of an individual’s sleep ...

ResMed launched NightOwl™, a home sleep apnea test that enhances user convenience with a small fingertip sensor and cloud data evaluation. Despite the broader market reacting negatively to new tariffs ...